UNeMed

MENU
  • Home
  • About
    • About Us
    • Annual Reports
    • Careers & Education
    • FAQs
    • In the News
    • Pipeline
    • Staff Directory
    • Innovation Ambassadors
    • Board of Directors
    • Startups
    • Success Stories
  • Services
    • Confidentiality
    • Intellectual Property
    • Innovation Ambassadors
    • Inventions
    • Licensing Process
    • Material Transfer
    • Startup Formation
    • Work with Us
  • Technologies
    • Cancer
    • Cardiovascular
    • COVID-19
    • Drug delivery
    • Infectious Diseases
    • Medical Devices
    • Metabolic
    • Neurologic
    • Open-MediciNE
    • Other
    • Research Tools
    • Software
    • Pipeline
    • Technology Portfolio
  • Resources
    • Innovation Ambassadors
    • Intellectual Property
    • Entrepreneurial Calendar
    • FAQs
    • Forms & Policies
    • Funding
    • Patents
    • Pipeline
    • Departments
    • Inventor Handbook
    • Technology Portfolio
    • More
      • UNMC Research
      • UNMC China
      • Nano Production
      • UNMC Core Facilities
      • UNL Core Facilities
      • iEXCEL
  • I-Week
    • Innovation Week
    • Innovation Awards
    • Demo Day
    • Past Events
  • Startups
    • UNeMed Startups
    • Steel Works Health Accelerator
    • Startup Formation
  • News
    • At the March 26, 2026, Morning Edition event at Catalyst Omaha, Howard Gendelman, MD—Chair of UNMC’s Department of Pharmacology and Experimental Neuroscience and Chief Science Officer at his startup, NeuralRegen—delivers a short presentation about the innovative therapies he and his company are developing for treating neurodegenerative diseases.

      Milk could key next-generation treatments for AD, PD

      Read article

    • Carecubes enters market, closes $6.5 million round

      Read article

    • Gendelman to lead next Idea Pub: Morning Edition

      Read article

    • The first cohort of the 2026 Steel Works Health Accelerator are (front, left to right) Steve Salzbrenner, Tim Crane, Ronald Krueger, (back) Kirk Zeller, Ashok Puri, Shiela Fields, Beth Beam, Marcia Shade, Ed O'Leary. Not Pictured: Chris Henkenius.

      First Steel Works Health Accelerator cohort announced

      Read article

    • Lenagh leads Idea Pub talk on industry engagement office

      Read article

  • Blog
    • Michael Dixon

      New proposal would tax, stifle US innovation

      Read article

    • Napkin contest helps small ideas become big solutions

      Read article

    • Year in Review: 2025

      Read article

    • What I learned as a tech transfer intern

      Read article

    • Year in Review: Highlights from 2024

      Read article

  • Contact
    • Contact Us
    • Staff Directory
    • Innovation Ambassadors

Research Tools

UNMC research tools available for licensing

Showing 1–16 of 18 resultsSorted by latest

  • Protein Engineering Platform

    Protein Engineering Platform

    Read more
  • Falcon Tube Insert

    Falcon Tube Insert

    Read more
  • Passive Hip Exoskeleton

    Passive Hip Exoskeleton

    Read more
  • Optimized Gait Tether

    Optimized Gait Tether

    Read more
  • Ankle-PLAST

    Ankle-PLAST

    Read more
  • Clinical Training Mat

    Clinical Training Mat

    Read more
  • Smart Leg Press

    Smart Leg Press

    Read more
  • Cryostat Sample Removal Device

    Cryostat Sample Removal Device

    Read more
  • Deconvolution of NGS mixtures

    Deconvolution of NGS mixtures

    Read more
  • GEMs for COVID-19

    GEMs for COVID-19

    Read more
  • a. Diagrammatic illustration showing the anatomical structures of ovary and oviduct and the surgical equipment used for GONAD procedure. A small amount of solution is injected by direct insertion of a glass micropipette through oviduct wall located at the region between the ampulla and infundibulum. Immediately after injection, in vivo electroporation is performed on the entire oviduct. C. The oviduct dissected on day 0.7 exhibits shrinkage of the ampulla (arrow), and zygotes isolated from the day 0.7 ampulla have fewer cumulus cells, which will less likely hamper the uptake of exogenous nucleic acids/proteins upon electroporation

    i-GONAD

    Read more
  • Enhance nanofiber mat properties

    Enhance nanofiber mat properties

    Read more
  • Easi-CRISPR

    Easi-CRISPR

    Read more
  • Panc02-MUC1 cells

    Panc02-MUC1 cells

    Read more
  • Alcohol dehydrogenase-expressing VA-13 cells

    Alcohol dehydrogenase-expressing VA-13 cells

    Read more
  • NR-6-R cells

    NR-6-R cells

    Read more
  • 1
  • 2
  • →

unemed  
  • Cancer (12)
  • Cardiovascular (4)
  • COVID-19 (12)
  • Drug delivery (7)
  • Infectious Diseases (23)
  • Medical Devices (41)
  • Metabolic (2)
  • Neurologic (2)
  • Online Store (15)
  • Open-MediciNE (2)
  • Other (12)
  • Research Tools (18)
  • Software (20)
unemed UNeMed
986099 Nebraska Medical Center
Omaha, NE 68198-6099
402-559-2468
unemed@unmc.edu
  • About
  • Services
  • Technologies
  • Resources
  • Innovation Week
  • News
  • Blog
  • Contact

Photos on flickr

  • UNeMed
  • Privacy Policy
  • Terms & Conditions of Use

© 2026 UNeMed | All Rights Reserved. Contact Webmaster.